Target intelligence / Profile preview

HIV-1 Tat protein (Trans-Activator of Transcription) (Tat)

Target
Tat
Molecular classification
Viral regulatory protein, Transcription factor, RNA-binding protein
01

Overview

HIV-1 Tat (Trans-Activator of Transcription) is a small, essential regulatory viral protein of 84–104 amino acids that functions as the master switch controlling HIV-1 gene expression. The protein's primary role is to activate viral transcription by binding to a stem-loop RNA structure called the transactivating response element (TAR) located at the 5' end of all viral transcripts. Tat accomplishes this by recruiting the host cell super elongation complex (SEC), particularly the P-TEFb component, which phosphorylates and activates RNA polymerase II, enabling it to transcribe the complete viral genome. Beyond its direct role in viral replication, Tat modulates the expression of hundreds of cellular genes, effectively remodeling the host cell environment to support HIV production and persistence. The protein also interacts with chromatin-modifying enzymes and structural proteins, which can lead to chromosomal aberrations associated with HIV-induced oncogenesis. As a therapeutic target, Tat represents an important avenue for HIV cure strategies, as disrupting Tat function or its interactions with cellular transcriptional machinery could reverse HIV latency and eliminate persistent infections.

Other names
Trans-activator of transcriptionTransactivator proteinHIV-1 TatTat protein
02

Mechanism of action

Mechanism of action for targeting Tat involves disruption of Tat:TAR:P-TEFb complex formation, inhibition of Tat-mediated recruitment of transcriptional elongation factors, blocking Tat interactions with chromatin-modifying enzymes, and prevention of Tat-dependent viral transcription activation.

03

Biological functions

HIV-1 gene expression activation: The major function of Tat is activation of HIV-1 viral transcription by binding to the transactivating response element (TAR) RNATranscriptional elongation regulation: Tat recruits the positive transcription elongation factor b (P-TEFb) complex to release paused RNA polymerase II, converting it into a highly processive enzyme capable of transcribing the entire viral genomeChromatin remodeling: Tat recruits histone acetyltransferases (HATs) and chromatin-modifying complexes to the HIV-1 promoter, relieving nucleosome-mediated repressionCellular gene expression modulation: Tat interacts with approximately 568 cellular genes to modulate host cell gene expression and create an environment favorable for viral productionNuclear and nucleolar localization: Tat localizes to both the nucleoplasm and nucleolus depending on its concentration, with distinct functional roles in each compartment
04

Disease associations

HIV-1 infection: Essential for productive HIV-1 replicationHIV-induced oncogenesis: Tat can interact with chromatin proteins and potentially lead to chromosomal aberrations and oncogenesis in HIV-infected patientsAIDS-dementia complex: Tat has been detected in the central nervous system of HIV-infected patients with AIDS-dementia symptoms
05

Safety considerations

Off-target effects on host transcription: Tat modulates expression of numerous cellular genes, and therapeutic targeting could disrupt critical host cell functionsPotential for chromosomal instability: Tat interactions with chromatin proteins and chromosome condensation machinery could theoretically increase oncogenic risk if dysregulatedCentral nervous system penetration: Tat presence in the CNS complicates therapeutic design for neurological manifestations of HIV infection
06

Biomarkers

Tat protein localization patterns (nucleoplasmic vs. nucleolar distribution) correlate with viral infection state and Tat concentrationProteomic signatures of Tat expression, including enrichment of ribosomal biogenesis and metabolic pathway proteins

Beyond the preview

Go deeper on HIV-1 Tat protein (Trans-Activator of Transcription) (Tat).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HIV-1 Tat protein (Trans-Activator of Transcription) (Tat).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call